Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

STRATA Skin Sciences (SSKN) Equity Average (2016 - 2025)

STRATA Skin Sciences' Equity Average history spans 14 years, with the latest figure at $923000.0 for Q3 2025.

  • For Q3 2025, Equity Average fell 90.24% year-over-year to $923000.0; the TTM value through Sep 2025 reached $923000.0, down 90.24%, while the annual FY2024 figure was $8.8 million, 48.84% down from the prior year.
  • Equity Average for Q3 2025 was $923000.0 at STRATA Skin Sciences, down from $1.8 million in the prior quarter.
  • Across five years, Equity Average topped out at $26.0 million in Q3 2021 and bottomed at $923000.0 in Q3 2025.
  • The 5-year median for Equity Average is $18.1 million (2023), against an average of $16.1 million.
  • The largest annual shift saw Equity Average fell 0.43% in 2021 before it plummeted 90.24% in 2025.
  • A 5-year view of Equity Average shows it stood at $25.8 million in 2021, then decreased by 15.44% to $21.8 million in 2022, then tumbled by 33.81% to $14.4 million in 2023, then tumbled by 50.23% to $7.2 million in 2024, then plummeted by 87.16% to $923000.0 in 2025.
  • Per Business Quant, the three most recent readings for SSKN's Equity Average are $923000.0 (Q3 2025), $1.8 million (Q2 2025), and $4.0 million (Q1 2025).